Scott Roberts, M.A., Ph.D

Scott Roberts
Group Director
Professor, Health Behavior & Health Education
Director, U-M School of Public Health Genetics Program
Co-Director, Dual-Degree (M.P.H./M.S.) Program in Public Health and Genetic Counseling
Ph.D, Clinical Psychology, University of Michigan, 1999
M.A., Clinical Psychology, University of Michigan, 1996
B.A., English, Duke University, 1992
Phone Number: 
(734) 936-9854


Dr. Roberts is Professor in the Department of Health Behavior & Health Education (HBHE) and Co-Director of the U-M M.P.H./M.S. Dual-Degree Program in Public Health and Genetic Counseling. Prior to joining the HBHE faculty in Fall 2006, he was Assistant Professor in the Department of Neurology at Boston University School of Medicine, where he was Co-Director of the Education Core in the NIH-funded BU Alzheimer's Disease Center. At U-M, he serves as a core faculty member in the SPH Certificate Program in Public Health Genetics and directs the Genomics, Health & Society Program within the U-M Center for Bioethics & Social Sciences in Medicine. Dr. Roberts' research interests focus on the process and impact of genetic risk assessment for adult-onset disorders. He has served since 2001 as Co-Principal Investigator of the Risk Evaluation & Education for Alzheimer's Disease (REVEAL) Study, an NIH-funded series of clinical trials assessing the psychological and behavioral impact of genetic risk disclosure for Alzheimer's disease. In its fourth trial, the REVEAL Study will examine the effects of APOE genotype-based risk disclosure to individuals with mild cognitive impairment (MCI) and their study partners. In addition, Dr. Roberts is joint PI of a NIH-funded project to examine the motivations, attitudes and behaviors of consumers receiving personal genomics services. He is also site PI within a NIH-funded multi-site consortium developing a web-based genomic risk education program for primary care providers. Finally, Dr. Roberts collaborates with investigators at the U-M Comprehensive Cancer Center on projects to develop and evaluate the following: web-based education and risk communication programs in breast cancer; protocols for returning individual cancer genetic test results to research participants; and protocols for disclosing germline and tumor sequencing results to advanced cancer patients.